#USA #Clinical Trials #Conshohocken #Suvoda #Agentic RTSM

Suvoda's Revolutionary Agentic RTSM Solution for Clinical Trials

In the landscape of clinical research, the transition from contract signing to actual trial launch can often extend into months, creating obstacles for sponsors eager to provide effective treatments to patients. Recognizing this challenge, Suvoda, a renowned global leader in clinical trial technology, has unveiled its latest innovation—the agentic RTSM (Randomization and Trial Supply Management) solution. This state-of-the-art platform employs cutting-edge AI technology to expedite the process, cutting crucial trial launch times by as much as 80%.

The Challenge in Clinical Trials

The startup phase of clinical trials has long been recognized as a bottleneck in the research process. For sponsors, delays not only hinder progress but can also impact the timely delivery of necessary therapies to patients. The emergence of a solution that can significantly reduce these long-standing delays is thus an imperative leap forward.

How the Agentic RTSM Works

Suvoda's agentic RTSM is engineered within a broader AI strategy. By leveraging its innovative AI assistant, Sofia, Suvoda aims to achieve three critical outcomes:

1. Accelerating Study Development: The agentic RTSM dramatically slashes the time frame from project initiation to user acceptance testing (UAT) to just two weeks. This swift transition allows sponsors to initiate patient recruitment sooner.
2. Enhancing User Experience: The new system is designed to simplify access to trial information for sponsors and sites, minimizing administrative burdens and facilitating a more streamlined process.
3. Delivering Intelligent Insights: The integration of AI provides study teams with enhanced visibility into trial statuses, supporting data-driven decision-making.

At the core of the agentic RTSM's functionality are various AI agents that accelerate different phases of study configuration, customization, and software testing. Unlike traditional methods that require rebuilding systems from scratch for every project iteration, this solution utilizes Suvoda's patented platform to offer rapid configuration and deployment. Its architecture allows for a shared data layer encompassing comprehensive trial modality data refined from thousands of complex clinical studies.

Voices Behind the Revolution

Jagath Wanninayake, CEO of Suvoda, emphasizes the urgency and complexity of modern clinical trials, stating, "Our clients should not be hindered by technology. With our agentic RTSM, we aim to remove the friction in trial startup, ensuring sponsors can recruit patients sooner and that sites experience an intelligent, responsive process."

As part of their ongoing commitment to enhancing their offerings, Suvoda is currently collaborating with select early users to deploy the agentic RTSM across broader operational bases, thus reinforcing their service capabilities. In tandem, enhancements to Sofia are underway to support tracking, provide proactive alerts, and ensure swift actions are taken to smooth the study process.

E.K. Koh, Product Head at Suvoda, elaborates on the broader vision behind this strategic development: "The agentic RTSM is a pioneering step toward an ambitious AI strategy. We believe that speed, quality, and experience do not have to come at the cost of each other—they can all advance together."

Conclusion: A Commitment to Patients

At the heart of Suvoda's innovations lies a commitment not only to sponsors and trial sites but ultimately to patients awaiting new treatments. A faster startup process is not merely an operational target; it signifies a step toward expediting access to vital medications.

As Suvoda continues to refine its AI-driven solutions, it reinforces its mission to ensure clinical trials remain focused on one fundamental goal: delivering better healthcare solutions to those in need.

About Suvoda

Suvoda is a global leader in clinical trial technology, offering a real-time software platform that empowers sponsors and CROs to make informed decisions, while enabling sites and patients to engage calmly and effectively in clinical studies. With interconnected, action-oriented software solutions and top-notch services, Suvoda supports over 6,000 clinical trials across more than 115 countries. Headquartered near Philadelphia, with additional offices globally, Suvoda has consistently maintained customer satisfaction ratings above the industry average, cementing its position as a trusted partner in clinical research.